Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 179,222 shares at $13.96 ($2.4M) on 2018-12-19, disclosed to the SEC on 2018-12-21.
Open-market sale of $2.4M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.17 | 423 | $6K | 0.2% |
| 2 | $13.19 | 640 | $8K | 0.4% |
| 3 | $13.20 | 1,261 | $17K | 0.7% |
| 4 | $13.21 | 64,989 | $859K | 35.7% |
| 5 | $13.21 | 64,989 | $859K | 35.7% |
| 6 | $13.96 | 240 |
| $3K |
| 0.1% |
| 7 | $13.96 | 23,023 | $321K | 13.4% |
| 8 | $13.96 | 23,023 | $321K | 13.4% |
| 9 | $13.96 | 180 | $3K | 0.1% |
| 10 | $13.96 | 454 | $6K | 0.3% |
| Total | $13.41 avg | 179,222 | $2.4M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |